MediClin AGSTU:MED 77 OCF Yield % is 51.25 as of Jul. 02, 2026, which is 33% above its 10-year median of 38.61. GuruFocus rates STU:MED with a GF Score™ of 77/100 and a GF Value™ of €2.95 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 684 Healthcare Providers & Services companies, MediClin AG ranks better than 96.93% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for MediClin AG's OCF Yield % or its related term are showing as below:
STU:MED'
s OCF Yield % Range Over the Past 10 Years
Min: 5.81 Med: 38.61 Max: 78.88
Current: 51.25
During the past 13 years, the highest OCF Yield % of MediClin AG was 78.88%. The lowest was 5.81%. And the median was 38.61%.
STU:MED's OCF Yield % is ranked better than 96.93% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 5.48
vs STU:MED: 51.25
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
MediClin AG OCF Yield % Related Terms
MediClin AG OCF Yield % Historical Data
* Premium members only.
The historical data trend for MediClin AG's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, MediClin AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MediClin AG OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's OCF Yield % distribution charts can be found below:
* The bar in red indicates where MediClin AG's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MediClin AG (STU:MED) has a OCF Yield % of 51.25 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MediClin AG and its competitors. This is 33% above median its historical median of 38.61. Over the past decade, MediClin AG's OCF Yield % has ranged from 5.81 to 78.88. According to the industry distribution chart, MediClin AG ranks #21 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 3.1%.
Is MediClin AG's OCF Yield % too high?
MediClin AG's current OCF Yield % of 51.25 is 33% above median its 10-year median of 38.61. Over the past 10 years, this metric has ranged from a low of 5.81 to a high of 78.88. The Healthcare Providers & Services industry median OCF Yield % is 5.48. MediClin AG's value of 51.25 is 835.2% above this industry median. Based on the distribution chart, MediClin AG ranks #21 out of 684 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MediClin AG has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MediClin AG ranks #21 out of 684 companies for OCF Yield %. This places MediClin AG in the top 3% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.48. MediClin AG's value of 51.25 is 835.2% above this benchmark. Historically, MediClin AG's own OCF Yield % has ranged from 5.81 to 78.88 over the past decade. While the company's 10-year median is 38.61 vs. the industry median of 5.48, MediClin AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.48, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MediClin AG's current OCF Yield % of 51.25 is 835.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MediClin AG and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MediClin AG's current OCF Yield % is 51.25, which is 33% above median its own 10-year median of 38.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (STU:MED) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.95, compared to a current price of €3.84 — trading 30.2% above its estimated fair value. The current OCF Yield % is 51.25, which is 33% above median its 10-year median of 38.61 and 835.2% above the Healthcare Providers & Services industry median of 5.48. MediClin AG's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For MediClin AG (STU:MED), the current OCF Yield % is 51.25 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MediClin AG (STU:MED) Overvalued in 2026?
Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued.
The current stock price of €3.84 is trading 30.2% above its estimated GF Value™ of €2.95.
GuruFocus considers MediClin AG to be Modestly Overvalued.
Key valuation signals for STU:MED:
OCF Yield %: 51.25 (33% above median its 10-year median of 38.61)
GF Value™: €2.95 vs. price of €3.84 (30.2% above fair value)
Industry Position: 835.2% above the Healthcare Providers & Services median (#21 of 684)
No single metric tells the full story. See the STU:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
77GF Score
Get the complete analysis for STU:MED
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MED has been successfully added to your 
